BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38546056)

  • 1. Investigation of Plasma Cell-Free DNA and MiRNA in Cholangiocarcinoma and Opisthorchiasis Viverrini Patients.
    Prasopdee S; Pholhelm M; Yusuk S; Tangphatsornruang S; Butthongkomvong K; Kunjantarachot A; Phanaksri T; Kulsantiwong J; Tesana S; Thitapakorn V
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):739-746. PubMed ID: 38546056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis.
    Rodpai R; Luvira V; Sadaow L; Sukeepaisarnjaroen W; Kitkhuandee A; Paonariang K; Sanpool O; Ittiprasert W; Mann VH; Intapan PM; Brindley PJ; Maleewong W
    Int J Infect Dis; 2022 Mar; 116():80-84. PubMed ID: 34954313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta as a potential biomarker for
    Prasopdee S; Yingchutrakul Y; Roytrakul S; Pholhelm M; Phanaksri T; Kunjantarachot A; Kulsantiwong J; Butthongkomvong K; Tesana S; Sathavornmanee T; Thitapakorn V
    Parasitology; 2022 Feb; 149(2):171-180. PubMed ID: 35234600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma checkpoint protein 1 (Chk1) as a potential diagnostic biomarker for opisthorchiasis and cholangiocarcinoma.
    Phanaksri T; Yingchutrakul Y; Roytrakul S; Prasopdee S; Kunjantarachot A; Butthongkomvong K; Tesana S; Sathavornmanee T; Thitapakorn V
    Cancer Biomark; 2022; 33(1):43-55. PubMed ID: 34366327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group.
    Silakit R; Loilome W; Yongvanit P; Thongchot S; Sithithaworn P; Boonmars T; Koonmee S; Titapun A; Khuntikeo N; Chamadol N; Techasen A; Namwat N
    Parasitol Int; 2017 Aug; 66(4):479-485. PubMed ID: 26456596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of salivary antibodies to crude antigens of Opisthorchis viverrini in opisthorchiasis and cholangiocarcinoma patients.
    Chaiyarit P; Sithithaworn P; Thuwajit C; Yongvanit P
    Clin Oral Investig; 2011 Aug; 15(4):477-83. PubMed ID: 20446100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Potential Biomarkers for
    Aksorn N; Roytrakul S; Kittisenachai S; Leelawat K; Chanvorachote P; Topanurak S; Hamano S; Lek-Uthai U
    In Vivo; 2018; 32(4):871-878. PubMed ID: 29936472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current State of Knowledge on Blood and Tissue-Based Biomarkers for Opisthorchis viverrini-induced Cholangiocarcinoma: A Review of Prognostic, Predictive, and Diagnostic Markers.
    Kafle A; Suttiprapa S
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):25-41. PubMed ID: 38285765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
    Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocarcinoma in experimental hamsters with long-standing Opisthorchis viverrini infection.
    Songserm N; Prasongwattana J; Sithithaworn P; Sripa B; Pipitkool V
    Asian Pac J Cancer Prev; 2009; 10(2):299-302. PubMed ID: 19537899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the risk factors for opisthorchiasis and cholangiocarcinoma in Thailand.
    Prasopdee S; Rojthongpond T; Chitkoolsamphan Y; Pholhelm M; Yusuk S; Pattaraarchachai J; Butthongkomvong K; Kulsantiwong J; Phanaksri T; Kunjantarachot A; Tesana S; Sathavornmanee T; Thitapakorn V
    Parasites Hosts Dis; 2023 Nov; 61(4):463-470. PubMed ID: 38043542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional analysis of mitogenic miRNA of the carcinogenic liver fluke Opisthorchis viverrini.
    Tan S; Thanan R; Sripa B; Suttiprapa S
    Acta Trop; 2024 Aug; 256():107243. PubMed ID: 38719083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma phosphoproteome and differential plasma phosphoproteins with opisthorchis viverrini-related cholangiocarcinoma.
    Kotawong K; Thitapakorn V; Roytrakul S; Phaonakrop N; Viyanant V; Na-Bangchang K
    Asian Pac J Cancer Prev; 2015; 16(3):1011-8. PubMed ID: 25735322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of c-Ski oncoprotein in carcinogenesis of cholangiocacinoma induced by Opisthorchis viverrini and N-nitrosodimethylamine.
    Boonmars T; Wu Z; Boonjaruspinyo S; Puapairoj A; Kaewsamut B; Nagano I; Pinlaor S; Yongvanit P; Wonkchalee O; Juasook A; Sudsarn P; Srisawangwong T
    Pathol Oncol Res; 2011 Jun; 17(2):219-27. PubMed ID: 20853076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct miRNA signatures associate with subtypes of cholangiocarcinoma from infection with the tumourigenic liver fluke Opisthorchis viverrini.
    Plieskatt JL; Rinaldi G; Feng Y; Peng J; Yonglitthipagon P; Easley S; Laha T; Pairojkul C; Bhudhisawasdi V; Sripa B; Brindley PJ; Mulvenna JP; Bethony JM
    J Hepatol; 2014 Oct; 61(4):850-8. PubMed ID: 25017828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma.
    Boonjaraspinyo S; Wu Z; Boonmars T; Kaewkes S; Loilome W; Sithithaworn P; Nagano I; Takahashi Y; Yongvanit P; Bhudhisawasdi V
    Parasitol Int; 2012 Mar; 61(1):145-50. PubMed ID: 21777692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention].
    Buisson Y
    Bull Soc Pathol Exot; 2017 Feb; 110(1):61-67. PubMed ID: 28105582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function association of enhanced expressed genes between Opisthorchis viverrini and non Opisthorchis viverrini-related cholangiocarcinoma.
    Wiwanitkit V
    Rev Esp Enferm Dig; 2008 Jul; 100(7):439-40. PubMed ID: 18808295
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinoma.
    Saengboonmee C; Seubwai W; Wongkham C; Wongkham S
    Cancer Epidemiol; 2015 Jun; 39(3):274-8. PubMed ID: 25910864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori GroEL Seropositivity Is Associated with an Increased Risk of Opisthorchis viverrini-Associated Hepatobiliary Abnormalities and Cholangiocarcinoma.
    Jala I; Almanfaluthi ML; Laha T; Kanthawong S; Tangkawattana S; Saichua P; Suttiprapa S; Sripa B
    Korean J Parasitol; 2021 Aug; 59(4):363-368. PubMed ID: 34470087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.